Crossmark

Concomitant Delivery of Pirarubicin and Salinomycin Synergistically Enhanced the Efficacy of Cancer Therapy and Reduced the Risk of Cancer Relapse

Published Online: 2024-09-07

Authors

Anees, Mohd

Gupta, Priya

Kaur, Harshdeep

Kharbanda, Surender

Singh, Harpal https://orcid.org/0000-0001-7082-7407
License Information

Text and Data Mining valid from 2024-09-07

Version of Record valid from 2024-09-07
More Information

Article History

Received: 8 May 2024

Accepted: 8 August 2024

First Online: 7 September 2024

Declarations

:

: Authors have no potential conflicts of interest.

Document is current